Publications by authors named "Tim Buchanan"

Claim this Profile
C
Combined Assessment of Function and Survival to Demonstrate the Effect of Treatment on Progressive Supranuclear Palsy.
Massimiliano Germani, Irene Rebollo Mesa, Tim J Buchanan, Steven De Bruyn, Teresa Gasalla

Mov Disord· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Brain Stimulation and Levodopa Affect Gait Variability in Parkinson Disease Differently.
Zi H Su, Salil Patel, Bronwyn Gavine, Tim Buchanan, Marko Bogdanovic

Neuromodulation· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study.
Marta F Pereira, Tim Buchanan, Günter U Höglinger, Marko Bogdanovic, George Tofaris

BMJ Neurol Open· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategy Adherence: A Specific and Rapidly Progressive Deficit in Progressive Supranuclear Palsy.
Maksymilian A Brzezicki, Marko Bogdanovic, Tim Buchanan, James J FitzGerald, Chrystalina A Antoniades

Mov Disord Clin Pract· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning.
Maarten De Vos, John Prince, Tim Buchanan, James J FitzGerald, Chrystalina A Antoniades

Gait Posture· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of levodopa on saccades - Oxford Quantification in Parkinsonism study.
Zhongjiao Lu, Tim Buchanan, Christopher Kennard, James J FitzGerald, Chrystalina A Antoniades

Parkinsonism Relat Disord· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring brain synaptic vesicle protein 2A with positron emission tomography and [F]UCB-H.
Mohamed Ali Bahri, Alain Plenevaux, Joël Aerts, Christine Bastin, Guillaume Becker, Tim Buchanan

Alzheimers Dement (N Y)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
Jeffrey T Guptill, Vern C Juel, Janice M Massey, Amanda C Anderson, Manisha Chopra, Tim Buchanan

Autoimmunity· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A.
Sergio Estrada, Mark Lubberink, Alf Thibblin, Margareta Sprycha, Tim Buchanan

Nucl Med Biol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain.
Geoffrey I Warnock, Joël Aerts, Mohamed Ali Bahri, Florian Bretin, Christian Lemaire, Tim Buchanan

J Nucl Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H.
Florian Bretin, Geoffrey Warnock, Mohamed Ali Bahri, Joël Aerts, Nathalie Mestdagh, Tim Buchanan

EJNMMI Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra- and interstudy reproducibility of coronary artery diameter measurements in magnetic resonance coronary angiography.
Jennifer Keegan, Paramate Horkaew, Tim J Buchanan, Trevor S Smart, Guang-Zhong Yang

J Magn Reson Imaging· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis